Combined blockade of the renin-angiotensin system;Blocage combine du systeme renine-angiotensine

Archives des Maladies du Coeur et des Vaisseaux

Volumn 92, Issue 6, 1999, Pages 735-739

  Azizi, M ^b   Menard, J ^a  

^a Hôpital Broussala   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN ANTAGONIST; BRADYKININ RECEPTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; LOSARTAN; ANGIOTENSIN II; DIPEPTIDYL CARBOXYPEPTIDASE;

ALDOSTERONE BLOOD LEVEL; ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFICACY; DRUG INHIBITION; DRUG TOLERANCE; HYPERTENSION; KIDNEY FUNCTION; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; REVIEW; SODIUM DEPLETION; ANIMAL; ARTICLE; DISEASE MODEL; DRUG ANTAGONISM; HUMAN; PHYSIOLOGY;

ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; PEPTIDYL-DIPEPTIDASE A; RATS; RENIN-ANGIOTENSIN SYSTEM;

EID: 0033019142     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Timmermans PB, Wong PC, Chiu AT et al. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993 ; 45 : 205-51.
2. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995 ; 95 : 651-7.
3. Nakajima M, Hutchinson HG, Fujinaga M et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the ATI receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci OSA 1995 ; 92 : 10663-7.
4. Levy BI, Benessiano J, Henrion D et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996 ; 98 : 418-25.
5. Liu YH, Yang XP, Sharov VG et al. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors. J Clin Invest 1997 ; 99 : 1926-35.
6. Sabri A, Levy BI, Poitevin P et al. Differential roles of ATI and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 1997 ; 17 : 257-64.
7. Ondetti MA, Rubin B, Cushman DW. Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 1977 ; 196 : 441-4.
8. Laragh JH, Lamport B, Sealey J, Alderman MH. Diagnosis ex juvantibus. Individual response patterns to drugs reveal hypertension mechanisms and simplify treatment. Hypertension 1988 ; 12 : 223-6.
9. Alderman MH, Madhavan S, Ooi WL, Cohen H, Sealey JE, Laragh JH. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med 1991 ; 324 : 1098-104.
10. Alderman MH, Ooi WL, Cohen H, Madhavan S, Sealey JE, Laragh JH. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens 1997 ; 10 : 1-8.
11. Testa MA, Anderson RB, Nackley JF, Hollenberg NK. Quality of life and antihypertensive therapy in men. A comparison of captopril with enalapril. The Quality-of-Life Hypertension Study Group. N Engl J Med 1993 ; 328 : 907-13.
12. Linz W, Wiemer G, Gohlke P, Unger T, Scholkens BA. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995 ; 47 : 25-49.
13. Erdös EG. Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990 ; 16 : 363-70.
14. Azizi M, Rousseau A, Ezan E et al. Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 1996 ; 97 : 839-44.
15. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med 1992 ; 117 : 234-42.
16. Okunishi H, Miyazaki M, Todo N. Evidence for a putatively new angiotensin II-generating enzyme in the vascular wall. J Hypertens 1984 ; 2 : 277-84.
17. Urata H, Kinoshita A, Misono KS, Bumpus FM, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990 ; 265 : 22348-57.
18. Ménard J, Guyene TT, Chatellier G, Kleinbloesem CH, Bernadet P. Renin release regulation during acute renin inhibition in normal volunteers. Hypertension 1991 ; 18 : 257-65.
19. Azizi M, Chatellier G, Guyene TT, Murieta-Geoffroy D, Ménard J. Additive effects of combined angiotensin-converting enzyme inhibition and angiotensin II antagonism on blood pressure and renin release in sodium-depleted normotensives. Circulation 1995 ; 92 : 825-34.
20. Azizi M, Guyene TT, Chatellier G, Wargon M, Ménard J. Additive effects of Losartan and Enalapril on blood pressure and plasma active renin. Hypertension 1997 ; 29 : 634-40.
21. Quinn SJ, Williams GH. Regulation of aldosterone secretion. Ann Rev Physiol 1988 ; 50 : 409-26.
22. Ménard J, Campbell DJ, Azizi M, Gonzales MF. Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight and renin in spontaneously hypertensive rats. Circulation 1997 ; 96 : 3072-8
23. Richer C, Bruneval P, Menard J, Giudicelli JF. Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats. Hypertension 1998 ; 31 : 692-8.
24. Webb RL, Navarrete AE, Davis S, de Gasparo M. Synergistic effects of combined converting enzyme inhibition and angiotensin Il antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats. J Hypertens 1998 ; 16 : 843-52.
25. Spinale FG, Mukherjee R, Iannmi JP et al. Modulation of the renin-angiotensin pathway through enzyme inhibition and specific receptor blockade in pacing-induced heart failure: II. Effects on myocyte contractile processes. Circulation 1997 ; 96 : 2397-406.
26. Jorde UP, lnfeld J, Cukon S et al. Incomplete suppression of Angiotensin-Converting-Enzyme (ACE) Inhibition in patients with chronic heart failure despite full dose ACE-Inhibitors. Circulation 1998 ; 98 (suppl. I) : 1-82.
27. Guazzi M, Agostoni P, Pontone G, Susini F, Palermo P, Guazzi MD. ATI receptor blockade, angiotensin converting enzyme inhibition and their combination in chronic heart failure. A comparative evaluation by cardiopulmonary exercise test. Circulation 1998 ; 98 (suppl. I) : 1-156.
28. Iyer SN, Chappell MC, Averill DB, Debra ID, Ferrario CM. Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 1998 ; 31 : 699-705.